The villain in this crucial matter is the pricing strategy followed by the manufacturers of medicines, implants and other hospital consumables — which, to say the least, is atrocious! The MRPs printed on most of these products are often between 1.5 to 10 times higher than what the hospitals have to actually pay. This huge gap — discounts between 35 and 90 per cent — allows (i) manufacturers to offer big incentives to doctors by way of commissions and foreign junkets and (ii) hospitals to exploit the patients. Even a cursory look at a hospital bill makes it clear that the room rent and even the consultants’ fees are only a fraction of the total amount — with medicines, consumables and prosthetics etc. accounting for the rest. There have been many investigative reports on the matter but no practical solution has been found other than capping prices of some medicines and stents.
It is a given that (i) the government alone cannot run a universal health care system in the country (ii) better qualified doctors prefer to work for the private sector and (iii) the private sector cannot purchase land at commercial market rates and afford to run a hospital. So, that leaves us with only two factors that need monitoring and strict control. First, the provision of a certain percentage of free beds to the poor, and secondly, pricing of medicines, consumables and prosthetics by the hospitals. All of them need to add decent margins, but these should not be exorbitant.
A dialogue with the manufacturers — at least the domestic ones — to stamp reasonable MRPs should also help. The joker in the pack would, of course, be the thousands of small and unorganised manufacturers of consumables that account for a bulk of the suppliers to even the biggest of hospitals. Krishan Kalra Gurugram
Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201 · E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
